---
title: "Hasti Finance Ltd (531387) — Share Price, Financials & Analysis"
symbol: "531387"
company: "Hasti Finance Ltd"
canonical: "https://tapetide.com/stocks/531387"
isin: "INE671D01014"
nse_symbol: "HASTIFINANCELTD"
bse_code: "531387"
sector: "Financial Services"
industry: "NBFC"
market_cap_cr: 9.1
generated_at: "2026-09-13T18:37:04.615Z"
---

# Hasti Finance Ltd (531387)

Canonical page: https://tapetide.com/stocks/531387

## Company

- **NSE Symbol:** HASTIFINANCELTD
- **BSE Code:** 531387
- **ISIN:** INE671D01014
- **Sector:** Financial Services
- **Industry:** NBFC
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** hastifinance.com

## About

Incorporated in 1994, Hasti Finance Ltd is in the business of providing financial and investing services[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:43:10.416773Z.

- **Market Cap:** ₹9.1 Cr
- **Classification:** Microcap
- **P/E (reported):** -1.5
- **EPS (TTM):** ₹-5.8
- **EPS (reported):** ₹0
- **Book Value:** ₹5.2
- **Price to Book:** 1.61
- **Dividend Yield:** 0%
- **ROE:** -68.56%
- **ROCE:** -68.56%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹0.18 Cr
- **Net Income:** ₹-5.24 Cr
- **EBITDA:** ₹-4.54 Cr
- **52-Week High:** ₹9.78
- **52-Week Low:** ₹4.96
- **RSI (14):** 73.87

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -37.3% over past five years.
- Company has a low return on equity of -32.8% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 0% | 0% | 0% |
| ebitda margin growth | 0% | — | — | — |
| net income growth | 100% | -36.1% | 948% | — |
| revenue growth | 0.1% | -64% | -43% | -37% |
| roce | — | — | — | -14.33% |
| roe | — | — | -24.24% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Revenue | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.09 | 0.03 | 0.03 | 0.03 | 0.05 |
| Expenses | 0.04 | 0.04 | 0.54 | 0.17 | 0.11 | 0.1 | 8.2 | 0.1 | 4.54 | 0.03 | 0.07 | 0.09 |
| Financing Profit | 0.07 | 0.07 | -0.49 | -0.06 | 0 | 0.01 | -8.09 | -0.01 | -4.51 | 0 | -0.04 | -0.04 |
| Financing Margin % | 63.64 | 63.64 | -445.45 | -54.55 | 0 | 9.09 | -7354.55 | -11.11 | -15033.33 | 0 | -133.33 | -80 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.07 | 0.07 | -0.49 | -0.06 | 0 | 0.01 | -8.09 | -0.01 | -4.51 | 0 | -0.04 | -0.04 |
| Tax % | 28.57 | 28.57 | -26.53 | 0 | — | 0 | 0 | 100 | 0 | — | 4250 | 0 |
| Net Profit | 0.06 | 0.05 | -0.37 | -0.06 | 0 | 0 | -8.09 | -0.02 | -4.51 | 0 | -1.73 | -0.04 |
| EPS in Rs | 0.06 | 0.05 | -0.34 | -0.06 | 0 | 0 | -7.46 | -0.02 | -4.16 | 0 | -1.6 | -0.04 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Revenue | 1.78 | 1.58 | 1.73 | 1.86 | 1.39 | 0.98 | 0.45 | 0.45 | 0.18 | 0.14 |
| Expenses | 1.43 | 1.42 | 1.41 | 1.55 | 1.26 | 1.46 | 0.98 | 8.59 | 4.73 | 4.73 |
| Financing Profit | 0.35 | 0.15 | 0.32 | 0.31 | 0.13 | -0.48 | -0.59 | -8.14 | -4.55 | -4.59 |
| Financing Margin % | 19.66 | 9.49 | 18.5 | 16.67 | 9.35 | -48.98 | -131.11 | -1808.89 | -2527.78 | -3278.57 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0.01 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 |
| Depreciation | 0.09 | 0.06 | 0.05 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0 |
| Profit before tax | 0.26 | 0.09 | 0.27 | 0.27 | 0.11 | -0.46 | -0.6 | -8.15 | -4.56 | -4.59 |
| Tax % | 7.69 | -233.33 | -55.56 | -103.7 | 27.27 | -26.09 | -16.67 | 0 | 37.28 | — |
| Net Profit | 0.25 | 0.3 | 0.42 | 0.55 | 0.08 | -0.34 | -0.51 | -8.15 | -6.26 | -6.28 |
| EPS in Rs | 0.23 | 0.28 | 0.39 | 0.51 | 0.07 | -0.31 | -0.47 | -7.52 | -5.78 | -5.8 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 |
| Reserves | 14.22 | 14.46 | 9.46 | 9.82 | 10.37 | 10.45 | 10.02 | 9.51 | 1.05 | -5.2 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 1.34 | 1.38 | 0.54 | 0.69 | 0.92 | 1.12 | 1.32 | 1.49 | 1.58 | 1.35 |
| Total Liabilities | 26.4 | 26.68 | 20.84 | 21.35 | 22.13 | 22.41 | 22.18 | 21.84 | 13.47 | 6.99 |
| Fixed Assets | 0.33 | 0.25 | 0.18 | 0.14 | 0.1 | 0.08 | 0.06 | 0.05 | 0.03 | 0.03 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 6.38 | 6.37 | 2.56 | 2.56 | 2.56 | 2.56 | 2.45 | 2.45 | 2.15 | 2.15 |
| Other Assets | 19.69 | 20.06 | 18.1 | 18.65 | 19.47 | 19.77 | 19.67 | 19.34 | 11.29 | 4.81 |
| Total Assets | 26.4 | 26.68 | 20.84 | 21.35 | 22.13 | 22.41 | 22.18 | 21.84 | 13.47 | 6.99 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.1 | -0.46 | 0.07 | -0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing Activity | 0.19 | 0.27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.09 | -0.19 | 0.07 | -0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -0.1 | -0.46 | 0.07 | -0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| CFO/OP | -33 | -117 | 62 | -16 | 0 | 0 | -6 | -26 | 0 | 0 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ROE % | 0.08 | 0.99 | 1.32 | 2.05 | 2.63 | 0.38 | -1.61 | -2.48 | -50.56 | -71.46 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 45.65% | 45.65% | 45.65% | 45.65% | 45.65% | 45.65% | 45.65% | 45.65% | 45.65% | 45.65% | 45.65% | 45.65% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 50.95% | 50.93% | 51.02% | 51% | 50.99% | 51.08% | 51.01% | 51.02% | 50.53% | 50.17% | 50.2% | 50.21% |
| Others | 3.4% | 3.42% | 3.34% | 3.35% | 3.37% | 3.28% | 3.34% | 3.33% | 3.82% | 4.18% | 4.15% | 4.14% |
| No. of Shareholders | 1212 | 1213 | 1263 | 1264 | 1284 | 1407 | 1442 | 1456 | 1569 | 1512 | 1488 | 1491 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 2 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 8.15 | Buy |
| EMA (10) | 8.1 | Buy |
| SMA (20) | 7.29 | Buy |
| EMA (20) | 7.55 | Buy |
| SMA (50) | 6.69 | Buy |
| EMA (50) | 7.14 | Buy |
| SMA (100) | 7.32 | Buy |
| EMA (100) | 7.33 | Buy |
| SMA (200) | 7.98 | Buy |
| EMA (200) | 7.59 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 77.61 | Sell |
| MACD (12,26,9) | 0.61 | Buy |
| Stochastic (14,3,3) | 99.65 | Sell |
| ADX (14) | 43.37 | Buy |
| Williams %R (14) | 0 | Sell |
| ATR (14) | 0.26 | Neutral |
| ROC (12) | 20.38 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 62.47 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Notice Of The 32Nd Annual General Meeting For The Financial Year 2025-26 To Be Held On Wednesday 30Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fb7a77f-0b8a-41dc-b857-e3b4e8e6135a.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67299ac3-898d-4eeb-810c-94440835fd8d.pdf) |
| 2026-09-05 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 05Th September 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13c315a1-b514-4d3e-b8b8-081aacb8cf95.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2009dbb1-e56e-44e4-9a17-22625a5451d3.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c952b51e-87a8-4675-b147-b5e4a58fece4.pdf) |
| 2026-08-10 | [Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f471c208-9390-4224-9772-a06cbbd45c3e.pdf) |
| 2026-08-07 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0db395a0-bbb4-4539-b163-f6fd0603119c.pdf) |
| 2026-06-25 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=114c53c5-f976-404f-8597-73ba5ecc7941.pdf) |
| 2026-05-30 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6125737-58ef-4c8b-8bb7-5608ad1e27f2.pdf) |
| 2026-05-30 | [Board Meeting Outcome for Revised Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14f7cb0c-0bf3-4e4d-93ca-fde03520c8fb.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Approval Of Unaudited Standalone Financial Results For The Quarter Ended 30Th June 2026 Together With The Limited Review Report Thereon](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac04b758-238c-452b-a25b-d30f4c20dfde.pdf) |
| 2026-05-30 | [Audited Financial Resultsresults-31-03-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84351ba0-5220-4a6b-9154-4c5e4911434b.pdf) |
| 2026-02-12 | [Results-Unaudited Financials Results For 31-12-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5a0f6ac-ef59-45a2-88a2-95ce971a9af9.pdf) |
| 2025-11-14 | [Unaudited Financial Results For The Quarter & Half Year Ended On September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=224d34da-c981-42f9-a3de-6383b1f208f8.pdf) |
| 2025-08-14 | [Unaudited Financial Results For The Quarter Ended 30Th June 2025 Together With The Limited Review Report Thereon.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f66cb856-f4e9-4f35-8d5a-eaaff71a6dc8.pdf) |
| 2025-05-30 | [Audited Standalone Financial Results Of The Company For The Fourth Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02c753cb-ce4f-4a27-9bfe-acf0321ee5f6.pdf) |
| 2025-02-13 | [Unaudited Financial Results For The Quarter And Nine Months Ended On December 31St 2024 Along With The Limited Review Report Herewith As Per Regulation 33 Of SEBI (Listing Obligations And Disclosure R](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0040d6a0-5df2-47c6-9876-d5bc9fb6599c.pdf) |
| 2024-11-14 | [Unaudited Financial Results For The Quarter & Half Year Ended On September 30, 2024 Along With The Limited Review Report Therewith As Per Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=962d85d6-241c-436b-9ba9-14f523e33e11.pdf) |
| 2024-08-14 | [UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED 30TH JUNE 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=025898cc-e20c-4e94-9df2-78724d7ee280.pdf) |
| 2024-05-30 | [Audited Financial Results For The Quarter And Financial Year Ended On 31St March, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c740d48a-04f3-4a47-80d6-a72648069dd3.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 January 2026 - One-to-one meeting with Coheron Wealth on Jan 9, 2026, 5-6pm at registered office. | [Analysts/Institutional Investor Meet/Con. Call Updates 6 January 2026 - One-to-one meeting with Coheron Wealth on Jan 9, 2026, 5-6pm at registered office.](https://nsearchives.nseindia.com/corporate/INFLUX_06012026144244_060126IHLInvestormeetscheduleSigned.pdf) |
| 5 March 2026 - TBS confirmed GMP compliance for Influx's Palghar plant; inspection Dec 9, 2025; valid five years; enables Tanzania registration. | [Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals 5 March 2026 - TBS confirmed GMP compliance for Influx's Palghar plant; inspection Dec 9, 2025; valid five years; enables Tanzania registration.](https://nsearchives.nseindia.com/corporate/INFLUX_05032026183842_050326IHLGMPCertificatesigned.pdf) |
| 5 March 2026 - Influx Healthtech plant visit scheduled March 10, 2026 at Kolgaon, Palghar facility for investors/analysts. | [Analysts/Institutional Investor Meet/Con. Call Updates 5 March 2026 - Influx Healthtech plant visit scheduled March 10, 2026 at Kolgaon, Palghar facility for investors/analysts.](https://nsearchives.nseindia.com/corporate/INFLUX_05032026162633_050326IHLPlantVisitSEAnnouncementSigned.pdf) |
| 4 February 2026 - Influx incorporated 100%-owned Olahey Wellness Pvt Ltd on Feb 3, 2026; paid-up capital Rs.100,000. | [Incorporation 4 February 2026 - Influx incorporated 100%-owned Olahey Wellness Pvt Ltd on Feb 3, 2026; paid-up capital Rs.100,000.](https://nsearchives.nseindia.com/corporate/INFLUX_04022026171421_InfluxHealthtechSusidiaryIncorporationSigned.pdf) |
| 4 Feb - Board meeting on 12 Feb 2026 to approve unaudited results for quarter ended 31 Dec 2025; trading window closed. | [Board Meeting Intimation for Approval Of Unaudited Quarterly Results For The Quarter Ended 31Sr December 2025 4 Feb - Board meeting on 12 Feb 2026 to approve unaudited results for quarter ended 31 Dec 2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eeb8d9f0-f057-4355-9cf5-356ea8e4c583.pdf) |
| 29 January 2026 - Q3 FY26: strong growth, capex for specialty manufacturing, Quick Snap™ machine, new product launches, strengthened order book. | [Updates 29 January 2026 - Q3 FY26: strong growth, capex for specialty manufacturing, Quick Snap™ machine, new product launches, strengthened order book.](https://nsearchives.nseindia.com/corporate/INFLUX_29012026165808_InfluxHealthtechQ39MFY26BusinessUpdateSigned.pdf) |
| 27 February 2026 - Virtual group meeting at Arihant Bharat Connect (Rising Stars 2026) on March 6, 2026, 10–11 AM. | [Analysts/Institutional Investor Meet/Con. Call Updates 27 February 2026 - Virtual group meeting at Arihant Bharat Connect (Rising Stars 2026) on March 6, 2026, 10–11 AM.](https://nsearchives.nseindia.com/corporate/INFLUX_27022026163726_270226_IHL_Investor_Meet_Signed.pdf) |
| 26 Mar - Trading window closed from April 1, 2026 until 48 hours after audited results for FY/Q4 March 31, 2026. | [Closure of Trading Window 26 Mar - Trading window closed from April 1, 2026 until 48 hours after audited results for FY/Q4 March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/31ee4b3a-60a7-460e-bda0-d8341b5a7b86.pdf) |
| 24 Jan - Reg 74(5) certificate: no dematerialisation requests for quarter ended 31 December 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 24 Jan - Reg 74(5) certificate: no dematerialisation requests for quarter ended 31 December 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/da13fd17-fe91-4a5d-92e7-a1439a4b7087.pdf) |
| 24 February 2026 - Virtual one-to-one investor meeting with Youfirst Capital on March 2, 2026, 4:00–5:00 PM. | [Analysts/Institutional Investor Meet/Con. Call Updates 24 February 2026 - Virtual one-to-one investor meeting with Youfirst Capital on March 2, 2026, 4:00–5:00 PM.](https://nsearchives.nseindia.com/corporate/INFLUX_24022026162150_240226IHLInvestorMeetAnnouncementSigned.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/INFLUX_18112025161632_181125IHLEarningscallTranscriptsSigned.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://nsearchives.nseindia.com/corporate/INFLUX_22082025161428_InfluxHealthtechAugust2025InvestorPresentation.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_27446_INFLUX_2024_2025_A_14082025183648.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a795d5bf-5b9a-4336-944b-a6a8409ca3d0.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/19d431ed-c881-4706-87ed-e1f35efc9d31.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4e3c1642-ed0b-467a-9dfe-873c6a3b879c.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531387/77004531387.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531387/71404531387.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/531387/66207531387.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/531387/5313870319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/531387/5313870318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/531387/5313870317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:37:04.615Z.